Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Demonstrating Analytical Comparability in Analytical Development Santoshkumar Khatwani at Sangamo Therapeutics and James Wilkinson at Refyn The presentation will focus on challenges in analytical comparability for gene therapy products. In addition, orthogonal methods along with some of th... 1 month ago | 86 mins Characterization of Residual Impurities in Gene Therapy Drug Products Jessica Townsend, at Intellia Therapeutics Eric S. Bishop, at Cygnus Technologies Characterization of residual impurities for gene therapy drug products is particularly challenging due to the complex nature of the final products as ... 2 months ago | 84 mins Orthogonal Measures of LVP Using DLS, NTA, & Micro Flow Cytometry Jim Richardson at Interius Biotherapeutics and Kevin Lance at Unchained Labs Full Title: Orthogonal Measures of Lentiviral Particle Attributes Using DLS, NTA, and Micro Flow Cytometry Orthogonal Measures of Lentiviral Particl... 1 month ago | 65 mins Gene Therapy 2.0: Leveraging Transgene Cassette Engineering Ben Josey, PhD, Corning Life Sciences, and Gabriela Denning, PhD, Expression Therapeutics LLC Novel gene therapies are entering the clinic and generating clinical data readouts at an unprecedented rate. As with any new therapy, the key readouts... 3 months ago | 65 mins Amping Up Yield and Enhancing Quality in Adherent Cell Culture Scale-Up Catherine Siler, Ph.D. The field of gene and cell therapy has experienced rapid growth over the past decade, and the expansion of the number of therapeutics coincides with t... 2 months ago | 40 mins Technologies and Platform Approach for Optimizing Downstream Purification... Ashish Saksule at Vertex Pharmaceuticals and Dr Alejandro Becerra at Thermo Fisher Scientific Full title: Technologies and Platform Approach for Optimizing Downstream Purification of Viral Vectors The promising success stories and advancement ... May 10, 2023 2:00pm Bringing Gene Therapies to Life: Navigating Scale Up, Partnerships, and Barriers Ben Josey Ph.D., Field Application Scientist, Corning Life Sciences Cell and gene therapies are rapidly advancing and with that, the need to effectively generate large volumes of viable cell and gene therapy products t... 8 months ago | 29 mins Corning® Ascent® FBR - Innovative technology for scalable adherent cell culture Sascha Kiesslich, PhD, Corning Life Sciences Advances in the science of gene and cell therapies have created rapid growth in the industry, with the common challenge of producing therapeutic cells... 4 months ago | 34 mins Efficient AAV Production Scale-up to Accelerate Gene Therapy Development Chris Reardon, Associate Scientist, Dyno Therapeutics Success in gene therapy relies on the ability to safely and precisely deliver a genetic payload to the intended target cells. This presentation descri... 8 months ago | 23 mins Single Use Process for Production of AAV Gene Therapy Products Lance Marquardt at PTC Therapeutics, Vikas Gupta, at Repligen, Rachel Legmann at Repligen, and Gilbert Huang at Repligen An overview of single use manufacturing for the production of AAV gene therapy products with comparisons to traditional monoclonal antibody production... 10 months ago | 120 mins Load more
